BMO cuts FactSet Research stock price target on valuation

FactSet reported Q2 FY2026 EPS $4.46 vs $4.37 consensus and revenue $611.0M vs $604.62M, with annual subscription value growth of 6.7%. BMO cut its price target to $257 (maintained Market Perform), Stifel cut to $248 from $295 (Hold), and Morgan Stanley cut to $228 from $307 (Equalweight); the stock has risen ~12% over the past week. Management said ~10% of ASV is non‑proprietary and characterized AI as deepening client engagement, but analysts remain cautious on longer‑term AI risk and margin impacts.

Analysis

The market reaction appears to be pricing a near-term view that management’s repositioning and AI-enabled engagement will offset aggressive reinvestment. That trade-off creates a two-stage return profile: a 6–18 month phase where revenue/ARR compounding and buybacks drive EPS expansion, followed by a 18–36 month phase where AI tooling either re-prices data (downside) or expands premium services (upside) depending on how proprietary content is defended.

Second-order winners include niche analytics and workflow modules that can be cross-sold into existing client seats (higher ARPU) and vendors that provide proprietary alternative datasets — they become strategic to clients trying to differentiate models from commoditized feeds. Conversely, vendors whose value is predominantly non-proprietary feed content face the greatest pricing pressure if clients adopt large-language model layers that standardize vanilla data ingestion.

Key risks are binary and time-phased: a near-term execution miss (next 2–3 quarters) around margin leverage or client upsell could compress multiples sharply; a medium-term structural risk (2–5 years) is the unbundling of pricing as AI layers commoditize baseline data. Monitoring signals: sequential ARR acceleration/deceleration, churn in top-50 clients, and product attach rates to AI modules — each will move valuation by large multiples.

The clean trade here is asymmetric: capture near-term multiple re-rating while explicitly capping long-term exposure to AI commoditization. That argues for instruments that are asset-light to own (calls or long equity sized modestly) paired with hedges tied to execution windows (short-dated puts or pair shorts on legacy data providers).

Key Decisions for Investors

• Tactical long FDS equity (6–12 months): accumulate on any 5–10% post-earnings pullback. Size 1–2% NAV initial position, target +25–35% upside if ARR/attach metrics show continued acceleration; hard stop at -12% from entry or on sequential ARR deceleration.
• Defined-risk options spread (9–12 months): buy 30-delta LEAP calls on FDS and finance by selling 2–3 month nearer-the-money calls in a rolling manner. Max loss = net premium; reward if sentiment and ARR sustain implies ~3x upside on premium with ~40–60% lower capital outlay vs outright equity.
• Pair trade (6–12 months): long FDS / short LSEG (or other legacy terminal/data provider) to express share-gain in analytics vs commoditized data. Target relative outperformance of 20–30% with pair hedge reducing macro beta; tighten if both show simultaneous ARR softness.
• Earnings protection (30–60 days): buy short-dated puts (outsized delta) sized to cover 30–40% of gross long exposure into the next two guidance points. Cost = insurance premium; rationale is to protect against a binary execution miss that historically compresses multiple quickly.